Genetic Testing and Molecular Biomarkers, an esteemed journal published by MARY ANN LIEBERT, INC, serves as a pivotal platform for advancing the field of genetic research and its applications in medicine. Focused on the innovative intersections of genetics and biomarker discovery, this journal has consistently contributed meaningful insights since its inception in 2009, with its scope evolving through 2024. With an ISSN of 1945-0265 and an E-ISSN of 1945-0257, it offers both traditional and open access options to cater to a broad audience of researchers, professionals, and students. Despite its current classification in the Q4 and Q3 quartiles for Genetics (clinical) and Medicine (miscellaneous) respectively, the journal remains committed to publishing high-quality, peer-reviewed articles that push the boundaries of knowledge in the field. As the landscape of genomic medicine continues to expand, Genetic Testing and Molecular Biomarkers is positioned as a crucial resource for disseminating cutting-edge discoveries and fostering interdisciplinary collaboration.

HEREDITAS, published by BMC, is a distinguished Open Access journal that has been a pivotal platform for the dissemination of cutting-edge research in the fields of genetics and biomedical sciences since its inception in 1920. With an impressive history spanning over a century, HEREDITAS has maintained a strong commitment to providing unrestricted access to high-quality scientific articles, ensuring that researchers and practitioners worldwide can share their findings and insights. This journal, which operates from its headquarters in the United Kingdom, is positioned within the Q3 quartile for Genetics and Q2 for miscellaneous Medicine categories according to the 2023 metrics, reflecting its significant yet evolving role in the academic landscape. Researchers are drawn to HEREDITAS not only for its legacy but also for its impact factor and contributions to the broader understanding of hereditary processes. The journal serves as an essential resource for students, scholars, and professionals who are keen on advancing the knowledge frontiers in genetics and related disciplines. With its open access policy implemented since 2005, HEREDITAS not only champions the principle of knowledge dissemination but also plays a crucial role in fostering collaborative research efforts across the globe.

Gene Reports is a prominent academic journal published by Elsevier that focuses on the rapidly evolving field of genetics. Launched in 2015, this journal serves as a pivotal platform for the dissemination of cutting-edge research, bridging the gap between basic and applied genetics studies. Although it currently holds a Q4 ranking in the Genetics category and stands at the 248th position out of 347 in Scopus rankings, its potential for growth is significant given the increasing interest in genetic research across various disciplines. With an E-ISSN of 2452-0144, Gene Reports aims to provide open access to original research articles, reviews, and short communications that advance the collective understanding of genetic mechanisms and their applications. As a publication that continues to shape the future of genetics, it is an essential resource for researchers, professionals, and students seeking to stay informed about the latest developments in this crucial field.

Human Genomics, published by BMC, is a leading open-access journal dedicated to advancing the field of genomics and its applications in health and disease. Since its inception in 2003, the journal has provided a vital platform for researchers to disseminate groundbreaking findings related to genetic research, contributing significantly to areas such as Drug Discovery, Genetics, Molecular Biology, and Molecular Medicine, as reflected in its Q1 and Q2 quartile rankings throughout 2023. With an ISSN of 1473-9542 and an E-ISSN of 1479-7364, Human Genomics not only delivers high-quality, peer-reviewed research but also ensures accessibility to a broader audience, empowering professionals, students, and academics to stay at the forefront of genomic science. Through its rigorous editorial standards and impactful publications, the journal fosters a collaborative environment for innovative research across the globe from its base in the United Kingdom. By promoting open access since its launch, Human Genomics continues to enhance the visibility and impact of genetic studies, making it an essential resource for anyone involved in the rapidly evolving field of human genomics.

RUSSIAN JOURNAL OF GENETICS is a significant platform in the field of genetics, published by PLEIADES PUBLISHING INC since its inception in 1996. With an ISSN of 1022-7954 and an E-ISSN of 1608-3369, the journal focuses on a wide array of topics within genetics, providing researchers, professionals, and students with insights into advancements and discoveries in this ever-evolving discipline. While it currently holds a Q4 ranking in the 2023 Genetics category according to Scopus, representing invaluable opportunities for knowledge dissemination, the journal is actively working to enhance its impact in future rankings. Readers will find the journal a repository of diverse genetic research findings, methodologies, and theoretical advancements. Although it is not an open-access journal, it is committed to serving the academic community through rigorous peer-reviewed articles. With a consistent publication trajectory spanning to 2024, the RUSSIAN JOURNAL OF GENETICS remains a crucial resource for those aspiring to stay at the forefront of genetic research and applications.

PLoS Genetics, published by the PUBLIC LIBRARY SCIENCE, is a leading open-access journal dedicated to advancing the field of genetics, molecular biology, and related disciplines. With its ISSN of 1553-7404, this esteemed journal has been offering unrestricted access to its content since 2005, fostering a global community of researchers, professionals, and students. Situated in the United States, its contributions can be found at 1160 Battery Street, Ste 100, San Francisco, CA 94111. As of 2023, PLoS Genetics proudly holds a Q1 ranking in multiple categories including Cancer Research, Ecology, Evolution, Behavior and Systematics, Genetics, and Molecular Biology, underscoring its impact in these vital scientific areas. The journal's commitment to disseminating high-quality research is reflected in its impressive Scopus rankings, with notable positions in various fields of study, ensuring that it remains a crucial resource for cutting-edge research and innovation. By providing an open-access platform, PLoS Genetics not only enhances the visibility of genetic research but also encourages collaborations and the sharing of knowledge that can lead to significant breakthroughs in science.

Molecular Genetics & Genomic Medicine, published by WILEY, is an esteemed and open-access journal that has been a prominent source of knowledge in the fields of genetics and molecular biology since its establishment in 2013. With an ISSN of 2324-9269, it aims to provide a platform for the dissemination of novel findings and innovative research that pushes the boundaries of genomics and its clinical applications. The journal holds a Q3 categorization in Genetics, Clinical Genetics, and Molecular Biology, reflecting its growing influence in these disciplines, as evidenced by its Scopus rankings. Researchers, professionals, and students alike will find valuable insights and advancements in genomic medicine, making this journal an essential resource for those dedicated to the understanding and application of genetic and molecular research in healthcare. Located at 111 River St, Hoboken, NJ, Molecular Genetics & Genomic Medicine continues to foster a global dialogue within the scientific community, ensuring accessible knowledge for all.

BIOCHEMICAL GENETICS, published by Springer/Plenum Publishers, is a prominent journal in the fields of biochemistry, genetics, and molecular biology, with a substantial impact on the scientific community since its inception in 1967. The journal holds a significant position within various academic quartiles, ranking Q2 in Ecology, Evolution, Behavior and Systematics, and Q3 in Biochemistry, Genetics, and Medicine (miscellaneous), among others, demonstrating its diverse and interdisciplinary reach. With an ISSN of 0006-2928 and an E-ISSN of 1573-4927, it is recognized for contributing critical research insights and methodologies that drive the fields of biochemical genetics forward. Although it is not an Open Access journal, it provides vital access options and resources for researchers globally, facilitating the dissemination of knowledge across institutions. Positioned within the competitive landscape of Scopus rankings, it maintains respectable standings across its focused areas, making it an invaluable resource for researchers, professionals, and students seeking to deepen their understanding of genetic mechanisms and biochemical processes.

Genetics Research, published by HINDAWI LTD, is a distinguished open access journal that has been at the forefront of genetic studies since its inception in 1960. With the transition to open access in 2019, this journal has expanded its accessibility, fostering knowledge dissemination across the global scientific community. Operating out of the United Kingdom, it provides a platform for innovative research in the fields of genetics and molecular biology, encompassing a broad range of topics that are highly relevant to medical sciences. As of 2023, it holds a Q4 classification in Genetics and a Q3 classification in miscellaneous Medicine, reflecting its ongoing commitment to scholarly excellence amidst shifting academic landscapes. While the journal's H-index remains unlisted, its indexed ranking within Scopus, with a rank of #325/328 in the Genetics category highlights the challenges ligated to its niche audience. Nevertheless, it serves as a crucial resource for researchers, professionals, and students eager to contribute to and stay informed on the latest genetic research trends and breakthroughs.

JOURNAL OF NEUROGENETICS, published by Taylor & Francis Ltd in the United Kingdom, is an influential platform for research and discussion in the dynamic field of neurogenetics. With an ISSN of 0167-7063 and an E-ISSN of 1563-5260, this journal has been committed to advancing our understanding of the genetic underpinnings of neurological conditions since its inception in 1983. Presently categorized in the Q3 quartile for Cellular and Molecular Neuroscience and Q2 for Genetics as of 2023, it serves as an essential resource for researchers and professionals seeking insights into the genetic factors influencing nervous system function and disorder. Although it does not offer open access, the journal remains a critical repository of knowledge with a broad scope that invites contributions spanning molecular genetics to neurobiology. With its rankings in Scopus reflecting a keen focus on robust academic standards, the JOURNAL OF NEUROGENETICS is vital for those dedicated to pioneering research and finding solutions in neurogenetics, making it a significant asset to students, scholars, and industry experts alike.